Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal antibody that binds to and inhibits activin receptor type-2B, with semaglutide ...

HTP, Chromium and More Now Available to Help Promote Appetite Control and Metabolic BalanceNew York, June 24, 2025 (GLOBE ...